We are live on ! Find out more
BLFS icon

BioLife Solutions

66 hedge funds and large institutions have $154M invested in BioLife Solutions in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 24 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 7

167% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 9

70% more capital invested

Capital invested by funds: $90.5M → $154M (+$63.3M)

22% more funds holding

Funds holding: 5466 (+12)

5.43% more ownership

Funds ownership: 40.68%46.11% (+5.4%)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
66
Holders Change
+12
Holders Change %
+22.22%
% of All Funds
1.42%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
19
Increased
24
Reduced
9
Closed
7
Calls
Puts
Net Calls
Net Calls Change

BLFS Hedge Fund Activity: Q1 2019 in Review

66 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q1 2019, worth a combined $154M — up 70% from $90.5M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new BLFS positions and 7 closed out — a net gain of 12 holders — while 24 added to existing stakes and 9 trimmed.

The largest buyer was Allianz Asset Management, opening a new position worth an estimated $3.19M. The largest seller was Renaissance Technologies, cutting an estimated $2.13M.

  • 66 institutional investors held BioLife Solutions (BLFS) as of Q1 2019, up from 54 in Q4 2018.
  • Funds reported $154M of BioLife Solutions stock for Q1 2019, up 70% quarter-over-quarter.
  • 19 funds opened new BioLife Solutions positions in Q1 2019 and 7 closed out, a net change of +12 holders.
  • The largest BioLife Solutions buyer in Q1 2019 was Allianz Asset Management, an estimated $3.19M added.
  • The largest BioLife Solutions seller in Q1 2019 was Renaissance Technologies, an estimated $2.13M sold.

Based on aggregated 13F filings for Q1 2019.